Skip to main content

Month: July 2021

Autolus Therapeutics to Report Second Quarter 2021 Financial Results on August 5, 2021, and will Participate in the William Blair Biotech Focus Conference 2021 on July 14, 2021

LONDON, July 08, 2021 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its second quarter 2021 financial results and operational highlights before open of U.S. markets on Thursday, August 5, 2021. Management will host a conference call and webcast at 8:30 am EDT/1:30 pm GMT to discuss the company’s financial results and provide a general business update. To listen to the webcast and view the accompanying slide presentation, please go to the events section of Autolus’ website. The call may also be accessed by dialing (866) 679-5407 for U.S. and Canada callers or (409) 217-8320 for international callers. Please reference conference ID 9757293. After the conference call, a replay will be...

Continue reading

GasLog Partners LP Announces Chief Executive Officer and Director Transition

Piraeus, Greece, July 08, 2021 (GLOBE NEWSWIRE) — GasLog Partners LP (“GasLog Partners” or the “Partnership”)(NYSE: GLOP) today announced senior management and board of director changes. The board of directors of GasLog Partners (the “Board”) is pleased to appoint Paolo Enoizi, currently Chief Operating Officer (“COO”) of the Partnership’s General Partner, GasLog Ltd. (“GasLog” and together with GasLog Partners, the “Group”), and GasLog Partners, as Chief Executive Officer (“CEO”) of the Partnership, effective August 1, 2021. Mr. Enoizi will continue to serve as COO of GasLog and GasLog Partners following his appointment as CEO of GasLog Partners. Paul Wogan will step down from his position as the Partnership’s CEO on July 31, 2021; however, he will remain CEO of GasLog. In addition, GasLog Partners announced...

Continue reading

Ikena Oncology to Participate in Targeted Oncology Panel at the William Blair Biotech Focus Conference 2021

BOSTON, July 08, 2021 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA), a targeted oncology company focused on developing therapies targeting key signaling pathways that drive the formation and spread of cancer, today announced that Dr. Mark Manfredi, CEO of Ikena Oncology, will participate in a panel discussing next-generation approaches to targeted oncology at the upcoming virtual William Blair Biotech Focus Conference. Details on the panel webcast can be found below.         Date: Thursday, July 15, 2021        Time: 9:00 – 9:45 a.m. ET        Webcast Link: Register The panel will be webcast live and can be accessed by visiting the Investors & Media section of the company’s website at www.ikenaoncology.com. The webcast will be archived for a period of 30 days following the conclusion of the live event. About Ikena...

Continue reading

Surface Oncology Appoints Denice Torres to Board of Directors

Brings 25 years of strategic leadership experience across healthcare CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Denice Torres will join the company’s board of directors. Ms. Torres has over 25 years of executive leadership experience in healthcare across the consumer, biopharmaceutical and medical device sectors. “I am thrilled to welcome Denice to the Surface board. She shares our commitment to bring transformational treatments to patients living with cancer,” said Rob Ross, M.D., chief executive officer at Surface. “She is an insightful leader in biopharma, with significant experience in leading companies through critical growth periods. In addition,...

Continue reading

Microbix Presenting Product Results to Industry

Two Abstracts Reporting on Cross-Platform Utility of Antigen & Serological QAPs™ MISSISSAUGA, Ontario, July 08, 2021 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it has been invited to present about the performance of its COVID-19 test quality assessment products (QAPs™) at “ECCMID 2021” the 31st annual congress organized by the European Society of Clinical Microbiology and Infectious Diseases, taking place in virtual format July 9-12, 2021. The first abstract poster presentation is titled “Advanced SARS-CoV-2 nucleocapsid protein swab-based formulation for use as cross-platform EQA sample and as a prospective Quality Control.” It reviews the performance of Microbix’s novel, innovative, and proprietary REDx™FLOQ®, PROCEEDx™FLOQ®, and...

Continue reading

F-Secure to publish January–June 2021 Half-year Financial Report on 15 July 2021

F-Secure Corporation, Press Release, 8 July 2021, at 14.00 EEST F-Secure to publish January–June 2021 Half-year Financial Report on 15 July 2021 F-Secure Corporation will publish its Half-year Financial Report for the period January-June 2021 on Thursday, 15 July 2021 at approximately 08.00 EEST. F-Secure’s CEO, Juhani Hintikka, and CFO, Eriikka Söderström, will present the results in a webcast starting at 14.00 EEST. The webcast will be held in English and can be accessed at https://f-secure.videosync.fi/2021-07-15-fsecureinterimreportq2. Questions are requested in written format in the webcast portal. Analysts following F-Secure are invited to the presentation at the company headquarters, Tammasaarenkatu 7, Helsinki, Finland. The presentation material and the webcast recording will be available on the company’s website at https://www.f-secure.com/en/investors. Contact...

Continue reading

Armstrong Flooring Announces Date for Second Quarter 2021 Results

LANCASTER, Pa., July 08, 2021 (GLOBE NEWSWIRE) — Armstrong Flooring, Inc. (NYSE: AFI) (“Armstrong Flooring” or the “Company”), a leader in the design and manufacture of innovative flooring solutions, announced today that the Company will release its second quarter 2021 financial results before the market opens on Wednesday, July 21, 2021. A webcast and conference call will be held that same day at 10:00 a.m. Eastern Time to review financial results, discuss recent events and conduct a question-and-answer session. Webcast and Conference Call:The live webcast will be available through the “Investor Relations” section of the Company’s website, www.armstrongflooring.com. Participants are advised to go to the site at least 15 minutes prior to the scheduled start time in order to register, download and install any necessary audio software....

Continue reading

Enento Group upgrades its net sales outlook for 2021

ENENTO GROUP PLC, INSIDE INFORMATION, 8 JULY 2021 AT 2.00 P.M. EEST Enento Group upgrades its net sales outlook for 2021 Enento Group Plc upgrades its net sales outlook for 2021, driven by the strong development in the second quarter. Net sales is expected to grow in 2021 in accordance with the long-term target range (5-10%), exceeding the mid-point of that range. In its previous future outlook, Enento Group has expected the net sales growth rate to be in the long-term target range (5-10%) but somewhat lower than the mid-point of the target range. The improved outlook is primarily due to the better-than-expected volume growth in the consumer information services in the Swedish market during the second quarter. In terms of EBITDA margin and investments, the future outlook remains unchanged. Updated 2021 outlook Net Sales: Enento Group...

Continue reading

Mesa Air Group Reports June 2021 Operating Performance

PHOENIX, July 08, 2021 (GLOBE NEWSWIRE) — Mesa Air Group, Inc. (NASDAQ: MESA) today reported Mesa Airlines’ operating performance for June 2021. Mesa Airlines reported 30,015 block hours in June 2021, a 224.6 percent increase from June 2020 as a result of increased flying due to industry recovery from the COVID-19 pandemic. The Company also reported a controllable completion factor of 98.58 percent and 99.97 percent for its American and United operations, respectively. Operating statistics for June 2021 and fiscal year 2021 YTD are included in the table below.  Jun-21   Jun-20   % Change     YTD FY2021   YTD FY2020   % Change  Block Hours              American 12,610   3,000   320.4 %   98,549   111,199   -11.4 %United 17,184   6,248   175.0 %   128,129   144,289   -11.2 %DHL 221   n/a   N/A     1,673   n/a   N/A  Total 30,015   9,247   224.6 %   228,351   255,488   -10.6 %                 Jun-21   Jun-20   %...

Continue reading

Hiab receives large MOFFETT order in the US

MOFFETT M8 55 NXMOFFETT M8 55 NXCARGOTEC CORPORATION, PRESS RELEASE JULY 8 2021 AT 2:00 PM EEST Hiab, part of Cargotec, has received an order for MOFFETT M8 55 NX truck mounted forklifts worth EUR 14.5 million from one of the leading home improvement companies in the US. The order was booked in Cargotec’s 2021 Q2 order intake. The forklifts ordered will be delivered between October 2021 and February 2022. All MOFFETT M8 NXs are delivered with connectivity enabled and premium access to HiConnect™ for two years. HiConnect Premium provides real-time insights into equipment utilisation, operation, and condition that can be used to optimise performance, safety and avoid unnecessary downtime. The Premium subscription gives fleet managers access to operation and operator performance data, individual site visits, service alerts...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.